Avalo Therapeutics, Inc.
AVTX
Revenue
249.00k
▲249.00k∞%
3 Months ChangeAssets
150.73M
▲52.28M▲53.10%
3 Months ChangeLiabilities
17.70M
▼-58.02M▼-76.62%
3 Months ChangeFree Cash Flow
-16.07M
▲2.27M▲12.38%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-08
Form 8-K
ID: 0001628280-24-042478
2024-09-09
Form 8-K
ID: 0001628280-24-039764
2024-09-04
Form 8-K
ID: 0001628280-24-039221
2024-08-14
Form 8-K
ID: 0001628280-24-037174
2024-08-12
Form 10-Q
ID: 0001628280-24-036591
2024-08-12
Form 8-K
ID: 0001628280-24-036589
2024-07-30
Form 8-K
ID: 0001628280-24-033437
2024-07-16
Form 8-K
ID: 0001628280-24-031923
2024-07-09
Form 8-K
ID: 0001628280-24-031426
2024-06-24
Form 8-K
ID: 0001628280-24-029564